CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancer-Reference-Cited by-同舟云学术

CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancer

Published:2024-04 Issue: Volume:587 Page:216724
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Murthy Divya^ORCID,Dutta Debasmita^ORCID,Attri Kuldeep S.^ORCID,Samanta Tagari^ORCID,Yang Sukjin,Jung Kwang Hwa^ORCID,Latario Sarah G.,Putluri Vasanta,Huang Shixia,Putluri Nagireddy,Park Jun Hyoung^ORCID,Kaipparettu Benny Abraham^ORCID

Funder

NIH

CDMRP

CPRIT

Publisher

Elsevier BV

Reference63 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc. Natl. Acad. Sci. U.S.A.,2001

3. Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies;Marra;NPJ Breast Cancer,2020

4. The clonal and mutational evolution spectrum of primary triple-negative breast cancers;Shah;Nature,2012

5. Endocrine-responsive breast cancer and strategies for combating resistance;Ali;Nat. Rev. Cancer,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protease activated receptor-1 regulates mixed lineage kinase-3 to drive triple-negative breast cancer tumorigenesis;Cancer Letters;2024-10

2. ASCT2 Regulates Fatty Acid Metabolism to Trigger Glutamine Addiction in Basal-like Breast Cancer;Cancers;2024-08-30

3. EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment;Journal of Biomedical Science;2024-08-20